Smith Darren Charlton
- SEC CIK
- 0002122447
In the past year, 1 open-market purchase filing worth – and no sales.
Current role at each company
- TLX Telix Pharmaceuticals LtdGroup Chief Financial Officeras of Sep 14, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 1 filing
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Smith Darren Charlton as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 14, 2026 (view filing)7:20 PM ET | Sep 7 | 7 daysLate | Smith Darren CharltonGroup Chief Financial Officer | PPurchase | +2.07K | $9.66 | +$20.0K | +17.4%14.0K after | Price outlier |